top of page
Pulp Fixin™
All Posts
What’s Next for Cold Chain in Biotech and Pharma? Expect the Styrofoam Crackdown.
As the global demand for biologics, mRNA therapies, and temperature-sensitive pharmaceuticals accelerates, the cold chain infrastructure that supports them is under increasing scrutiny—not just for performance, but for environmental impact. While 2026 promises smarter systems, tighter regulations, and expanded global distribution, there’s one constant still clinging to the supply chain: Styrofoam. 📦 The Problem with Performance—Isn’t Performance Expanded polystyrene (EPS), k
2 min read
PULPFIXIN NAMES CHAD JENKINS CHIEF EXECUTIVE OFFICER
PulpFixin has appointed Chad Jenkins as chief executive officer, effective immediately.
2 min read
Automation Meets Sustainability: Can Labs Have Both?
In the evolving landscape of biotech research, automation has become indispensable for enhancing efficiency and throughput. However, this...
2 min read
PULPFIXIN UNVEILS FIRST-EVER, MOISTURE-RESISTANT, FULLY COMPOSTABLE CRYOGENIC STORAGE BOXES FOR LABS
Replaces Plastic Cryoboxes with Durable, Moisture-Resistant, and Planet-Friendly Alternative Dayton, OH — March 21, 2025: PulpFixin , a...
2 min read
PULPFIXIN ANNOUNCES STRATEGIC DISTRIBUTION PARTNERSHIP WITH WILDCAT LABORATORY SOLUTIONS TO EXPAND SUSTAINABLE LAB PRODUCTS ACROSS THE UK AND EU
Dayton, OH — March 21 , 2025: PulpFixin , an innovator of sustainable laboratory products, announced today a new distribution partnership...
2 min read
bottom of page